Linagliptin monotherapy provides superior glycaemic control versus placebo or voglibose with comparable safety in Japanese patients with type 2 diabetes: a randomized, placebo and active comparator-controlled, double-blind study

2012 ◽  
Vol 14 (4) ◽  
pp. 348-357 ◽  
Author(s):  
R. Kawamori ◽  
N. Inagaki ◽  
E. Araki ◽  
H. Watada ◽  
N. Hayashi ◽  
...  
Keyword(s):  
Type 2 Diabetes ◽  
Glycaemic Control ◽  
Japanese Patients ◽  
Blind Study ◽  
Double Blind Study ◽  
Double Blind ◽  
Active Comparator ◽  
Control Versus

scholarly journals Optimizing Insulin Secretagogue Therapy in Patients With Type 2 Diabetes: A randomized double-blind study with repaglinide

Diabetes Care ◽  
2002 ◽  
Vol 25 (2) ◽  
pp. 342-346 ◽  
Author(s):  
O. Schmitz ◽  
S. Lund ◽  
P. H. Andersen ◽  
M. Jonler ◽  
N. Porksen
Keyword(s):  
Type 2 Diabetes ◽  
Blind Study ◽  
Double Blind Study ◽  
Double Blind ◽  
Insulin Secretagogue

Effects ofα-Lipoic Acid, Carnosine, and Thiamine Supplementation in Obese Patients with Type 2 Diabetes Mellitus: A Randomized, Double-Blind Study

2018 ◽  
Vol 21 (12) ◽  
pp. 1197-1203 ◽  
Author(s):  
Spyridon Karkabounas ◽  
Nikolaos Papadopoulos ◽  
Chryssa Anastasiadou ◽  
Chrysoula Gubili ◽  
Dimitrios Peschos ◽  
...  
Keyword(s):  
Diabetes Mellitus ◽  
Type 2 Diabetes ◽  
Type 2 Diabetes Mellitus ◽  
Lipoic Acid ◽  
Blind Study ◽  
Double Blind Study ◽  
Obese Patients ◽  
Double Blind
Sign in / Sign up

Export Citation Format

Share Document